"Designing Growth Strategies is in our DNA"

U.S. Contraceptive Drugs Market Size, Share & COVID-19 Impact Analysis, Product (Oral {Combined Contraceptives and Progestin-only Pills}, Injectable, and Patches), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels & NGOs, and Others), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108733

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Total Fertility Rate, U.S., 2022
    2. Pipeline Analysis, Key Players
    3. New Product Launches, Key Players
    4. Regulatory Scenario – U.S.
    5. Key Industry Developments- Mergers, Partnerships & Acquisitions
    6. Impact of COVID-19 on the Market
  5. U.S. Contraceptive Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Oral
        1. Combined Contraceptives
        2. Progestin-only Pills
      2. Injectable
      3. Patches
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Clinics
      4. Online Channel
      5. Public Channel & NGOs
      6. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Agile Therapeutics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Abbvie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Amneal Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Bayer AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Contraceptive Drugs Market Revenue Breakdown (USD Billion, %), By Product, 2022 & 2030

Figure 2: U.S. Contraceptive Drugs Market Value Share (%), by Product, 2022 & 2030

Figure 3: U.S. Contraceptive Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 4: U.S. Contraceptive Drugs Market Share (%), By Company, 2022

Table 1: U.S. Contraceptive Drugs Market Revenue (USD Billion) Forecast, by Product, 2019–2030

Table 2: U.S. Contraceptive Drugs Market Revenue (USD Billion) Forecast, by Oral Contraceptives, 2019–2030

Table 3: U.S. Contraceptive Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2030

U.S. Contraceptive Drugs Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 58
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase